Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells

被引:29
作者
Lundberg, P
Lerner, UH [1 ]
机构
[1] Umea Univ, Dept Oral Cell BIol, S-90187 Umea, Sweden
[2] Natl Inst Working Life, Ctr Musculoskeletal Res, Umea, Sweden
关键词
VIP; osteoblasts; osteoclasts; bone resorption; bone formation;
D O I
10.1002/jemt.10124
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
An intense network of nerve fibers can be demonstrated in skeletal tissues, not only in the periosteum but also within cortical bone, growth plate, and bone marrow. This neuro-osteogenic network expresses a restricted number of signalling molecules, including neuropeptides, neurotransmitters, and neurotrophins. Several lines of evidence indicate that receptors for these molecules are present on bone cells and that activation of these receptors leads to changes in bone cell activities. In addition, deletion of signalling molecules has been shown to alter bone metabolism. In the present review, these studies are summarized with a focus on distribution and effects of vasoactive intestinal peptide. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 61 条
[1]   Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders? [J].
Akopian, A ;
Demulder, A ;
Ouriaghli, F ;
Corazza, F ;
Fondu, P ;
Bergmann, P .
PEPTIDES, 2000, 21 (04) :559-564
[2]   Expression of neurotrophins and their receptors (TRK) during fracture healing [J].
Asaumi, K ;
Nakanishi, T ;
Asahara, H ;
Inoue, H ;
Takigawa, M .
BONE, 2000, 26 (06) :625-633
[3]   Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice [J].
Ballica, R ;
Valentijn, K ;
Khachatryan, A ;
Guerder, S ;
Kapadia, S ;
Gundberg, C ;
Gilligan, J ;
Flavell, RA ;
Vignery, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (07) :1067-1074
[4]  
BJURHOLM A, 1992, J BONE MINER RES, V7, P1011
[5]   FIXATION AND DEMINERALIZATION OF BONE TISSUE FOR IMMUNOHISTOCHEMICAL STAINING OF NEUROPEPTIDES [J].
BJURHOLM, A ;
KREICBERGS, A ;
SCHULTZBERG, M .
CALCIFIED TISSUE INTERNATIONAL, 1989, 45 (04) :227-231
[6]   NEUROPEPTIDE Y-IMMUNOREACTIVE, TYROSINE HYDROXYLASE-IMMUNOREACTIVE AND VASOACTIVE INTESTINAL POLYPEPTIDE-IMMUNOREACTIVE NERVES IN BONE AND SURROUNDING TISSUES [J].
BJURHOLM, A ;
KREICBERGS, A ;
TERENIUS, L ;
GOLDSTEIN, M ;
SCHULTZBERG, M .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 25 (2-3) :119-125
[7]  
Bliziotes M, 2000, J BONE MINER RES, V15, pS383
[8]   Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene [J].
Bliziotes, M ;
McLoughlin, S ;
Gunness, M ;
Fumagalli, F ;
Jones, SR ;
Caron, MG .
BONE, 2000, 26 (01) :15-19
[9]   Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells [J].
Cai, YQ ;
Xin, XN ;
Shim, GJ ;
Mokuno, Y ;
Uehara, H ;
Yamada, T ;
Agui, T ;
Matsumoto, K .
ENDOCRINOLOGY, 1997, 138 (06) :2515-2520
[10]   Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts [J].
Cornish, J ;
Callon, KE ;
Lin, CQ ;
Xiao, CL ;
Gamble, GD ;
Cooper, GJS ;
Reid, IR .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (08) :1302-1309